Technology companies have long seen medicine as a giant opportunity but have struggled to make inroads. That may be changing: Despite some high-profile failures, the tech industry is making itself felt in the pharmaceutical industry in a big way. Join STAT Senior Writer Matthew Herper and San Francisco Correspondent Rebecca Robbins for a two-part look into this burgeoning new ecosystem, featuring interviews with some of the area's biggest stars.
Technology companies have long seen medicine as a giant opportunity but have struggled to make inroads. That may be changing: Despite some high-profile failures, the tech industry is making itself felt in the pharmaceutical industry in a big way. Join STAT Senior Writer Matthew Herper and San Francisco Correspondent Rebecca Robbins for a two-part look into this burgeoning new ecosystem, featuring interviews with some of the area's biggest stars.
read more
show less